173 related articles for article (PubMed ID: 37630976)
21. Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets.
Larsen BS; Kissi E; Nogueira LP; Genina N; Tho I
Eur J Pharm Sci; 2024 Jan; 192():106619. PubMed ID: 37866675
[TBL] [Abstract][Full Text] [Related]
22. Tailoring immediate release FDM 3D printed tablets using a quality by design (QbD) approach.
Than YM; Titapiwatanakun V
Int J Pharm; 2021 Apr; 599():120402. PubMed ID: 33640426
[TBL] [Abstract][Full Text] [Related]
23. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
24. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms.
Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR
Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280
[TBL] [Abstract][Full Text] [Related]
25. QbD guided development of immediate release FDM-3D printed tablets with customizable API doses.
Crișan AG; Iurian S; Porfire A; Rus LM; Bogdan C; Casian T; Lucacel RC; Turza A; Porav S; Tomuță I
Int J Pharm; 2022 Feb; 613():121411. PubMed ID: 34954001
[TBL] [Abstract][Full Text] [Related]
26. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing?
Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C
Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815
[TBL] [Abstract][Full Text] [Related]
27. Design, Preparation and In Vitro Evaluation of Core-Shell Fused Deposition Modelling 3D-Printed Verapamil Hydrochloride Pulsatile Tablets.
Li R; Pan Y; Chen D; Xu X; Yan G; Fan T
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214169
[TBL] [Abstract][Full Text] [Related]
28. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing.
Skowyra J; Pietrzak K; Alhnan MA
Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545
[TBL] [Abstract][Full Text] [Related]
29. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing.
Li Q; Wen H; Jia D; Guan X; Pan H; Yang Y; Yu S; Zhu Z; Xiang R; Pan W
Int J Pharm; 2017 Jun; 525(1):5-11. PubMed ID: 28377316
[TBL] [Abstract][Full Text] [Related]
30. Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole.
Lee JH; Park C; Song IO; Lee BJ; Kang CY; Park JB
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890191
[TBL] [Abstract][Full Text] [Related]
31. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
Obeid S; Madžarević M; Ibrić S
Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
[TBL] [Abstract][Full Text] [Related]
32. 3D-printed tablets using a single-step hot-melt pneumatic process for poorly soluble drugs.
Kim SJ; Lee JC; Ko JY; Lee SH; Kim NA; Jeong SH
Int J Pharm; 2021 Feb; 595():120257. PubMed ID: 33486029
[TBL] [Abstract][Full Text] [Related]
33. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
[TBL] [Abstract][Full Text] [Related]
34. Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach.
Zhang J; Thakkar R; Zhang Y; Maniruzzaman M
Int J Pharm; 2020 Nov; 590():119945. PubMed ID: 33027633
[TBL] [Abstract][Full Text] [Related]
35. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
[TBL] [Abstract][Full Text] [Related]
36. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA
Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925
[TBL] [Abstract][Full Text] [Related]
37. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion.
Bhatt U; Malakar TK; Murty US; Banerjee S
Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008
[TBL] [Abstract][Full Text] [Related]
38. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
39. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
40. Polyvinyl Alcohol-Based 3D Printed Tablets: Novel Insight into the Influence of Polymer Particle Size on Filament Preparation and Drug Release Performance.
Crișan AG; Porfire A; Ambrus R; Katona G; Rus LM; Porav AS; Ilyés K; Tomuță I
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34062744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
